Edith Lau

6.1k total citations · 4 hit papers
25 papers, 4.0k citations indexed

About

Edith Lau is a scholar working on Molecular Biology, Orthopedics and Sports Medicine and Surgery. According to data from OpenAlex, Edith Lau has authored 25 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Orthopedics and Sports Medicine and 6 papers in Surgery. Recurrent topics in Edith Lau's work include Bone health and osteoporosis research (7 papers), Osteoarthritis Treatment and Mechanisms (6 papers) and Bone Metabolism and Diseases (6 papers). Edith Lau is often cited by papers focused on Bone health and osteoporosis research (7 papers), Osteoarthritis Treatment and Mechanisms (6 papers) and Bone Metabolism and Diseases (6 papers). Edith Lau collaborates with scholars based in Hong Kong, China and United States. Edith Lau's co-authors include Cristiano A. F. Zerbini, Felicia Cosman, GM Leung, Anthony J. Hedley, TQ Thach, Christl A. Donnelly, Steven Riley, LM Ho, Azra C. Ghani and Roy M. Anderson and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Edith Lau

25 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

2016 1.1k citations Felicia Cosman, Daria B. Crittenden et al. New England Journal of Medicine profile →
Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions

2003 810 citations Steven Riley, Christophe Fraser et al. Science profile →
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong

2003 682 citations Christl A. Donnelly, Azra C. Ghani et al. The Lancet profile →
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis

2016 581 citations Paul D. Miller, Gary Hattersley et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edith Lau Hong Kong	20	1.3k	1.1k	1.0k	877	770	25	4.0k
Noa Dagan Israel	18	116 0.1×	326 0.3×	217 0.2×	550 0.6×	2.7k 3.6×	37	4.0k
Sanjay Mukhopadhyay United States	34	122 0.1×	448 0.4×	833 0.8×	40 0.0×	1.1k 1.4×	158	4.6k
Ilya Novikov Israel	29	95 0.1×	432 0.4×	224 0.2×	49 0.1×	193 0.3×	96	3.7k
Vincent Lo Re United States	35	128 0.1×	178 0.2×	245 0.2×	65 0.1×	1.1k 1.4×	163	4.6k
Ka Chun Chong Hong Kong	28	52 0.0×	256 0.2×	113 0.1×	827 0.9×	934 1.2×	205	3.1k
Andreas Kronbichler Austria	39	23 0.0×	889 0.8×	480 0.5×	210 0.2×	882 1.1×	218	5.2k
Irene M. Shui United States	26	85 0.1×	311 0.3×	245 0.2×	41 0.0×	392 0.5×	67	2.2k
Noam Barda Israel	17	54 0.0×	291 0.3×	221 0.2×	563 0.6×	2.6k 3.4×	45	3.7k
Ali Gholamrezanezhad United States	28	58 0.0×	197 0.2×	773 0.8×	73 0.1×	1.5k 1.9×	215	4.7k
Zhe Xu China	24	22 0.0×	920 0.8×	969 1.0×	260 0.3×	4.7k 6.0×	84	7.4k

Countries citing papers authored by Edith Lau

Since Specialization

Citations

This map shows the geographic impact of Edith Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Lau more than expected).

Fields of papers citing papers by Edith Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edith Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Lau. The network helps show where Edith Lau may publish in the future.

Co-authorship network of co-authors of Edith Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Edith Lau. A scholar is included among the top collaborators of Edith Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edith Lau. Edith Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lau, Tang Ching, Dong‐Gune Chang, Chung‐Hwan Chen, et al.. (2025). Real-world persistence and compliance of denosumab versus alendronate among postmenopausal women with osteoporosis in Asia–Pacific. Journal of Bone and Mineral Metabolism. 44(1). 69–83. 1 indexed citations

Schnitzer, Thomas J., Xavier Chevalier, Edith Lau, et al.. (2025). Intra-articular MM-II for the treatment of knee osteoarthritis pain: Efficacy and safety results from a 26-week, phase 2b, placebo-controlled, double-blind, randomized dose-ranging trial. Osteoarthritis and Cartilage. 33(7). 897–906. 1 indexed citations

Fabbri, Alice, Lisa Parker, Cinzia Colombo, et al.. (2020). Industry funding of patient and health consumer organisations: systematic review with meta-analysis. BMJ. 368. l6925–l6925. 43 indexed citations

Lau, Edith, Rajani Dinavahi, Yu Cho Woo, et al.. (2020). Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study. Osteoporosis International. 31(4). 677–685. 21 indexed citations

Lau, Edith, Alice Fabbri, & Barbara Mintzes. (2018). How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional study. Australian Health Review. 43(4). 474–480. 12 indexed citations

Henriksen, Kim, I. Byrjalsen, J.R. Andersen, et al.. (2016). A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D. Bone. 91. 122–129. 56 indexed citations

Cosman, Felicia, Daria B. Crittenden, Jonathan D. Adachi, et al.. (2016). Romosozumab Treatment in Postmenopausal Women with Osteoporosis. New England Journal of Medicine. 375(16). 1532–1543. 1131 indexed citations breakdown →

Miller, Paul D., Gary Hattersley, Bente Juel Riis, et al.. (2016). Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis. JAMA. 316(7). 722–722. 581 indexed citations breakdown →

Karsdal, M.A., I. Byrjalsen, Kim Henriksen, et al.. (2009). The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study. Osteoarthritis and Cartilage. 18(2). 150–159. 82 indexed citations

10.

Kung, Annie W. C., et al.. (2006). A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6‐month study. Current Medical Research and Opinion. 22(5). 929–937. 24 indexed citations

11.

Yu, Clare Chung-Wah, R Y T Sung, Raymond So, et al.. (2005). Effects of Strength Training on Body Composition and Bone Mineral Content in Children Who Are Obese. The Journal of Strength and Conditioning Research. 19(3). 667–667. 49 indexed citations

12.

Lau, Edith, Frank W. Chan, David S.C. Hui, Alan Wu, & Peter C. K. Leung. (2005). Reduced bone mineral density in male Severe Acute Respiratory Syndrome (SARS) patients in Hong Kong. Bone. 37(3). 420–424. 27 indexed citations

13.

Woo, Jean, Edith Lau, Polly Lee, et al.. (2004). Impact of osteoarthritis on quality of life in a Hong Kong Chinese population.. PubMed. 31(12). 2433–8. 51 indexed citations

14.

Donnelly, Christl A., Azra C. Ghani, GM Leung, et al.. (2003). Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. The Lancet. 361(9371). 1761–1766. 682 indexed citations breakdown →

15.

Woo, Jean, Edith Lau, Chak Sing Lau, et al.. (2003). Socioeconomic impact of osteoarthritis in Hong Kong: Utilization of health and social services, and direct and indirect costs. Arthritis Care & Research. 49(4). 526–534. 62 indexed citations

16.

Riley, Steven, Christophe Fraser, Christl A. Donnelly, et al.. (2003). Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions. Science. 300(5627). 1961–1966. 810 indexed citations breakdown →

17.

Ko, Gary T.C., Juliana C.N. Chan, Jean Woo, et al.. (1998). The Reproducibility and Usefulness of the Oral Glucose Tolerance Test in Screening for Diabetes and other Cardiovascular Risk Factors. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 35(1). 62–67. 150 indexed citations

18.

Lau, Edith. (1996). The epidemiology of hip fracture in Asia: An update. Osteoporosis International. 6(S3). 19–23. 21 indexed citations

19.

Lau, Edith, Deborah Symmons, & Peter Croft. (1996). The Epidemiology of Hip Osteoarthritis and Rheumatoid Arthritis in the Orient. Clinical Orthopaedics and Related Research. 323(323). 81–90. 21 indexed citations

20.

Chan, Juliana C.N., et al.. (1996). The Metabolic Syndrome in Hong Kong Chinese. The interrelationships among its components analyzed by structural equation modeling. Diabetes Care. 19(9). 953–959. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact